PRESS RELEASE published on 09/09/2024 at 22:01, 1 year 11 months ago Abivax presents first-half 2024 financial results Abivax presents first-half 2024 financial results with a cash balance of EUR 222M at June 30, 2024. The company focuses on developing therapies for chronic inflammatory diseases Financial Results Abivax Therapeutics Chronic Inflammatory Diseases EUR 222M
BRIEF published on 08/29/2024 at 18:05, 1 year 11 months ago ABIVAX: Status of shares and voting rights as of July 31, 2024 Euronext Paris Voting Rights Actions Abivax Regulatory
BRIEF published on 08/06/2024 at 08:35, 2 years ago Abivax Reaches Key Milestone with Recruitment of 600 Patients for Phase 3 ABTECT Trial Patient Recruitment Abivax Obefazimod Ulcerative Colitis Clinical Test
PRESS RELEASE published on 08/06/2024 at 08:30, 2 years ago Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone Abivax announces ABTECT Phase 3 Trial surpasses 600-patient enrollment milestone, on track for full enrollment by early Q1 2025. Trial trends align with previous observations Abivax Obefazimod Ulcerative Colitis ABTECT Phase 3 Trial Enrollment Milestone
BRIEF published on 07/23/2024 at 18:05, 2 years ago ABIVAX: Number of shares and voting rights as of June 30, 2024 Voting Rights Euronext Actions AMF Abivax
BRIEF published on 07/23/2024 at 18:05, 2 years ago ABIVAX: Half-yearly review of the liquidity contract as of June 30, 2024 Liquidity Contract Actions Financial Transactions Abivax First Half Of 2024
BRIEF published on 07/22/2024 at 09:51, 2 years ago Threshold crossing by Deep Track Biotechnology Master Fund Voting Rights Abivax Crossing Threshold Off-market Acquisition Deep Track Biotechnology
BRIEF published on 07/15/2024 at 22:05, 2 years ago Abivax announces advances in its clinical program and updates its operations Treasury Ulcerative Colitis Nomination Update Clinical Program
PRESS RELEASE published on 07/15/2024 at 22:00, 2 years ago Abivax Provides Operational and Key Program Update Abivax provides operational and key program update, including progress on clinical trials, leadership changes, and financial update Leadership Changes Abivax Clinical Trials Operational Update Financial Update
BRIEF published on 06/28/2024 at 18:05, 2 years 1 month ago ABIVAX: Summary of the Number of Shares and Voting Rights as of May 31, 2024 Voting Rights Actions AMF Abivax Transparency
Published on 08/11/2026 at 07:00, 4 hours 11 minutes ago Alaska Energy Metals Announces Closing of Shares for Debt Settlement
Published on 08/11/2026 at 00:40, 10 hours 31 minutes ago CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 10 hours 46 minutes ago Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 11 hours 36 minutes ago NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 11 hours 41 minutes ago Condor and Element79 Agree on Restructured Terms for Lucero Project
Published on 08/11/2026 at 10:42, 29 minutes ago Aareal Bank arranges €128 million top-up facility for Lighthouse Properties’ Spanish retail portfolio
Published on 08/11/2026 at 10:35, 36 minutes ago Lifefit launches and appoints Neymar Jr. as global brand ambassador
Published on 08/11/2026 at 10:05, 1 hour 6 minutes ago The Ellinikon Sports Park Opens to All as Europe's Largest Urban Regeneration Project Accelerates Toward Completion
Published on 08/11/2026 at 10:00, 1 hour 11 minutes ago Rising heat, growing exposure, changing hazards: benign first half of 2026 masks rising natural catastrophe risk, finds Swiss Re Institute
Published on 08/10/2026 at 18:00, 17 hours 11 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 23 hours 17 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 23 hours 35 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 1 day 1 hour ago Number of shares and voting rights - July 2026 (In French only)
